Follow
Stephan Schaller
Stephan Schaller
Founder & CEO, esqLABS GmbH
Verified email at esqlabs.com - Homepage
Title
Cited by
Cited by
Year
Integrating cellular metabolism into a multiscale whole-body model
M Krauss, S Schaller, S Borchers, R Findeisen, J Lippert, L Kuepfer
PLoS computational biology 8 (10), e1002750, 2012
1402012
Open systems pharmacology community—an open access, open source, open science approach to modeling and simulation in pharmaceutical sciences
J Lippert, R Burghaus, A Edginton, S Frechen, M Karlsson, A Kovar, ...
CPT: pharmacometrics & systems pharmacology 8 (12), 878, 2019
962019
A generic integrated physiologically based whole‐body model of the glucose‐insulin‐glucagon regulatory system
S Schaller, S Willmann, J Lippert, L Schaupp, TR Pieber, A Schuppert, ...
CPT: pharmacometrics & systems pharmacology 2 (8), 1-10, 2013
902013
Safer chemicals using less animals: kick-off of the European ONTOX project
M Vinken, E Benfenati, F Busquet, J Castell, DA Clevert, TM de Kok, ...
Toxicology 458, 152846, 2021
572021
Robust PBPK/PD-based model predictive control of blood glucose
S Schaller, J Lippert, L Schaupp, TR Pieber, A Schuppert, T Eissing
IEEE Transactions on Biomedical Engineering 63 (7), 1492-1504, 2015
332015
A quantitative systems pharmacology kidney model of diabetes associated renal hyperfiltration and the effects of SGLT inhibitors
P Balazki, S Schaller, T Eissing, T Lehr
CPT: pharmacometrics & systems pharmacology 7 (12), 788-797, 2018
242018
A generic avian physiologically-based kinetic (PBK) model and its application in three bird species
V Baier, A Paini, S Schaller, CG Scanes, AJ Bone, M Ebeling, TG Preuss, ...
Environment international 169, 107547, 2022
172022
Quantitative comparison of avian and mammalian physiologies for parameterization of physiologically based kinetic models
CG Scanes, J Witt, M Ebeling, S Schaller, V Baier, AJ Bone, TG Preuss, ...
Frontiers in physiology 13, 858386, 2022
152022
Physiologically based simulations of deuterated glucose for quantifying cell turnover in humans
J Lahoz-Beneytez, S Schaller, D Macallan, T Eissing, C Niederalt, ...
Frontiers in immunology 8, 474, 2017
142017
A multiscale, model-based analysis of the multi-tissue interplay underlying blood glucose regulation in type I diabetes
F Wadehn, S Schaller, T Eissing, M Krauss, L Küpfer
2016 38th Annual International Conference of the IEEE Engineering in …, 2016
132016
Modeling and simulation of in vivo drug effects
J Lippert, R Burghaus, L Kuepfer, B Ploeger, S Schaller, W Schmitt, ...
New Approaches to Drug Discovery, 313-329, 2016
92016
A Physiologically‐Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP‐1 and GIP and the DPP4 Inhibitor Sitagliptin
P Balazki, S Schaller, T Eissing, T Lehr
CPT: pharmacometrics & systems pharmacology 9 (6), 353-362, 2020
82020
Human recessive osteopetrosis
M Helfrich, B Perdu, F Coxon
Osteologie 18 (04), 260-267, 2009
72009
Quantitative morphometric, physiological, and metabolic characteristics of chickens and mallards for physiologically based kinetic model development
CG Scanes, J Witt, M Ebeling, S Schaller, V Baier, AJ Bone, TG Preuss, ...
Frontiers in Physiology 13, 858283, 2022
52022
Integration of artificial neural network and physiologically based biopharmaceutic models in the development of sustained‐release formulations
F Severino Martins, L Borges, R Oliveira do Couto, S Schaller, ...
Biopharmaceutics & Drug Disposition 44 (4), 335-343, 2023
42023
Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study
C Maass, S Schaller, A Dallmann, K Bothe, D Müller
Toxicological Sciences 192 (1), 59-70, 2023
42023
Automated optimal glycaemic control using a physiology based pharmacokinetic, pharmacodynamic model
S Schaller
Aachen, Techn. Hochsch., Diss., 2014, 2015
42015
Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans
R Geci, D Gadaleta, MG de Lomana, R Ortega-Vallbona, E Colombo, ...
Archives of Toxicology, 1-18, 2024
32024
Reproductive toxicity in birds predicted by physiologically-based kinetics and bioenergetics modelling
T Martin, B Bauer, V Baier, A Paini, S Schaller, P Hubbard, M Ebeling, ...
Science of the Total Environment 912, 169096, 2024
32024
Evaluation of the drug‐drug interaction potential of treosulfan using a physiologically‐based pharmacokinetic modelling approach
S Schaller, FS Martins, P Balazki, S Böhm, J Baumgart, RA Hilger, ...
British Journal of Clinical Pharmacology 88 (4), 1722-1734, 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–20